| P50 | author | Linda L Demer | Q42562196 |
| P2093 | author name string | Yin Tintut | |
| P2860 | cites work | Role of the mouse ank gene in control of tissue calcification and arthritis | Q22254612 |
| | Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 |
| | Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta | Q24594206 |
| | Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis | Q24595023 |
| | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 |
| | Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1 | Q24651261 |
| | Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification | Q24684936 |
| | Phosphate regulation of vascular smooth muscle cell calcification | Q28139908 |
| | Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension | Q28244253 |
| | Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification | Q28301225 |
| | Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein | Q28304798 |
| | Warfarin-induced artery calcification is accelerated by growth and vitamin D | Q28370245 |
| | Regression of medial elastocalcinosis in rat aorta: a new vascular function for carbonic anhydrase | Q28564685 |
| | Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 |
| | Pattern formation by vascular mesenchymal cells. | Q30637027 |
| | Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. | Q53628335 |
| | Decreased aortic compliance aggravates subendocardial ischaemia in dogs with stenosed coronary artery | Q54057318 |
| | Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. | Q54074255 |
| | Cartilaginous transformation of the aortic valve. | Q54517497 |
| | MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. | Q54759836 |
| | Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats | Q56905413 |
| | Volumetric BMD and Vascular Calcification in Middle-Aged Women: The Study of Women's Health Across the Nation | Q57392301 |
| | Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies | Q57740221 |
| | ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain | Q58375412 |
| | Arterial Calcification and Not Lumen Stenosis Is Highly Correlated With Atherosclerotic Plaque Burden in Humans: A Histologic Study of 723 Coronary Artery Segments Using Nondecalcifying Methodology | Q58492269 |
| | Increased Atherosclerotic Lesion Calcification in a Novel Mouse Model Combining Insulin Resistance, Hyperglycemia, and Hypercholesterolemia | Q59703596 |
| | Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries | Q62056241 |
| | Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? | Q64378644 |
| | Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. | Q64913104 |
| | Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes and is identical to osteopontin (secreted phosphoprotein I, 2aR) | Q67900090 |
| | Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia | Q71024578 |
| | Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro | Q71609188 |
| | Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies | Q71636568 |
| | Matrix vesicles in atherosclerotic calcification | Q71671852 |
| | Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction | Q72726594 |
| | Increased osteoprotegerin serum levels in men with coronary artery disease | Q73106368 |
| | Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway | Q73209080 |
| | Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 |
| | Clusterin regulates vascular smooth muscle cell nodule formation and migration | Q73420769 |
| | The impact of calcification on the biomechanical stability of atherosclerotic plaques | Q73549958 |
| | Bone formation and inflammation in cardiac valves | Q73635711 |
| | Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis | Q73684776 |
| | Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study | Q74152546 |
| | Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression | Q74351433 |
| | Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques | Q77350558 |
| | High coronary artery calcium scores pose an extremely elevated risk for hard events | Q77480610 |
| | Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice | Q77520948 |
| | Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography | Q77738539 |
| | Identification and characterization of calcifying valve cells from human and canine aortic valves | Q77982316 |
| | Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17 beta-estradiol | Q78004667 |
| | Bone formation in carotid plaques: a clinicopathological study | Q78040365 |
| | High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells | Q79148900 |
| | Calcific aortic valve stenosis in old hypercholesterolemic mice | Q79317350 |
| | Uremia-related vascular calcification: more than apatite deposition | Q79408629 |
| | Vascular calcification: not so crystal clear | Q79744868 |
| | Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients | Q79870466 |
| | Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice | Q79903873 |
| | Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients | Q80078924 |
| | Vascular calcification: contribution of parathyroid hormone in renal failure | Q80101278 |
| | The relation between mitral annular calcification and mortality in patients undergoing diagnostic coronary angiography | Q80339517 |
| | Coronary calcification improves cardiovascular risk prediction in the elderly | Q80357431 |
| | Endochondral bone formation is involved in media calcification in rats and in men | Q80406983 |
| | Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis | Q80413873 |
| | Role of osteoprotegerin in arterial calcification: development of new animal model | Q80576674 |
| | Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome | Q81470493 |
| | Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro | Q81632097 |
| | Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells | Q81676413 |
| | Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway | Q82928082 |
| | Pathology of the vulnerable plaque | Q83187650 |
| | Matrix metalloproteinase inhibition attenuates aortic calcification | Q83323452 |
| | Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals | Q42717983 |
| | Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption | Q43604722 |
| | Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. | Q43604734 |
| | Patterns and risk factors for systemic calcified atherosclerosis | Q43690938 |
| | Oxidative stress modulates osteoblastic differentiation of vascular and bone cells | Q43702897 |
| | Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. | Q43764592 |
| | Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. | Q43819702 |
| | Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease | Q43865169 |
| | Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells | Q44173368 |
| | Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice | Q44429147 |
| | Cartilaginous metaplasia in calcified diabetic peripheral vascular disease: Morphologic evidence of enchondral ossification | Q44431335 |
| | Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption | Q44590734 |
| | Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice | Q44592811 |
| | Prediction of coronary events with electron beam computed tomography | Q44627202 |
| | Serum Levels of the Fetuin-Mineral Complex Correlate with Artery Calcification in the Rat | Q44631933 |
| | Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo | Q44690058 |
| | Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. | Q44734905 |
| | Arterial calcifications and bone histomorphometry in end-stage renal disease | Q44949005 |
| | Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. | Q45124317 |
| | Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification | Q45200610 |
| | Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes | Q45249096 |
| | N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. | Q45935973 |
| | Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. | Q45946808 |
| | cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. | Q45996887 |
| | Monocyte/macrophage regulation of vascular calcification in vitro | Q46083654 |
| | Chondrogenesis mediated by PPi depletion promotes spontaneous aortic calcification in NPP1-/- mice | Q46197496 |
| | A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis | Q46535596 |
| | Genetic determination of cartilaginous metaplasia in mouse aorta. | Q46608623 |
| | Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives | Q46841631 |
| | Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial | Q46895799 |
| | A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice | Q46951764 |
| | Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function | Q46954793 |
| | Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin | Q47578435 |
| | Involvement of matrix metalloproteinases and tenascin-C in elastin calcification | Q47773556 |
| | Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease? | Q50684275 |
| | Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. | Q50707613 |
| | Chondrogenic and adipogenic potential of microvascular pericytes. | Q50784818 |
| | Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. | Q51626934 |
| | The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. | Q52119912 |
| | Aortic calcification in haemodialysis patients with diabetes mellitus. | Q53575137 |
| | Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study | Q31111874 |
| | Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: An electron-beam CT study | Q32085711 |
| | Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors | Q33182532 |
| | Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification | Q33291152 |
| | Vascular smooth muscle and arterial calcification | Q33894026 |
| | TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. | Q34145009 |
| | Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification | Q34217171 |
| | Oral anticoagulant treatment: friend or foe in cardiovascular disease? | Q34334786 |
| | Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study | Q34370169 |
| | Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin | Q34491036 |
| | A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps | Q35075416 |
| | Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses | Q35087914 |
| | Angiogenesis and marrow stromal cell fates: roles in bone strength | Q35541093 |
| | T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves | Q35580436 |
| | Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve | Q35584233 |
| | BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells | Q35643930 |
| | Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis) | Q35754273 |
| | Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification | Q35833202 |
| | Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis | Q36368706 |
| | Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo | Q36371196 |
| | Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). | Q36482441 |
| | Mechanisms of vascular calcification | Q36697880 |
| | The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis | Q36860289 |
| | Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease | Q36918536 |
| | Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. | Q37188485 |
| | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 |
| | Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation | Q37633944 |
| | High-density lipoprotein regulates calcification of vascular cells. | Q39265314 |
| | Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. | Q40251686 |
| | Bone morphogenetic protein expression in human atherosclerotic lesions. | Q40304303 |
| | Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients | Q40322189 |
| | Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. | Q40324778 |
| | Multilineage potential of cells from the artery wall. | Q40622386 |
| | Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography | Q40695603 |
| | Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells | Q40817294 |
| | The role of Gla proteins in vascular calcification. | Q40836210 |
| | Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus | Q40933115 |
| | Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle | Q41094750 |
| | THE FORMATION OF TRUE BONE WITH CELLULAR (RED) MARROW IN A SCLEROTIC AORTA. | Q41910297 |
| | Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype | Q41950206 |
| | Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves | Q42539622 |
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vascular calcification | Q54911504 |
| P304 | page(s) | 2938-48 | |
| P577 | publication date | 2008-06-03 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Vascular calcification: pathobiology of a multifaceted disease | |
| P478 | volume | 117 | |